HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sake J Van der Wall Selected Research

idarucizumab

1/2019Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sake J Van der Wall Research Topics

Disease

2Hemorrhage
02/2019 - 01/2019
1Thromboembolism
02/2019
1Stroke (Strokes)
02/2019
1Venous Thromboembolism
01/2019
1Atrial Fibrillation
01/2019

Drug/Important Bio-Agent (IBA)

2AnticoagulantsIBA
02/2019 - 01/2019
1idarucizumabIBA
01/2019
1ecarinIBA
01/2019
1DabigatranFDA Link
01/2019
1Vitamin KFDA Link
01/2019

Therapy/Procedure

2Therapeutics
02/2019 - 01/2019